Form 4: Revvity Director Peter Barrett Acquires RSUs

Revvity, Inc. reports that Director Peter Barrett was granted restricted stock units, vesting in April 2027.

Summary

• Director Peter Barrett received a grant of restricted stock units (RSUs) on May 7, 2026.
• Each RSU represents a contingent right to receive one share of Revvity's common stock.
• The RSUs are scheduled to fully vest on April 27, 2027, coinciding with the issuer's next annual shareholder meeting.
• Vesting is contingent upon Mr. Barrett's continued service through the vesting date.
• Accelerated vesting may occur upon Mr. Barrett's death, disability, or qualifying retirement.
• Vesting may also accelerate if Mr. Barrett's service terminates within 12 months following a change in control of the company.
• Following the transaction, Mr. Barrett beneficially owns 28,293 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it pertains to standard director compensation and does not provide new financial performance data or strategic shifts.

Positives

• Director Peter Barrett's acquisition of RSUs indicates continued commitment and alignment with the company's long-term performance.
• The vesting schedule is tied to continued service and corporate events, aligning incentives.
• The grant of RSUs is a common form of executive compensation designed to retain talent and motivate performance.

Negatives

• The filing does not disclose the number of RSUs granted, only the resulting ownership after a prior transaction.
• The value of the RSUs at the time of grant is not specified.

Risks

• Vesting is subject to continued service, meaning forfeiture is possible if Mr. Barrett leaves the company before April 27, 2027.
• A change in control could lead to accelerated vesting, potentially impacting the timing of equity realization for the director.
• The value of the RSUs is tied to the future performance of Revvity's stock, which carries inherent market risk.

Future Outlook

The filing primarily details a compensation event for a director and does not contain forward-looking financial guidance or strategic outlook statements for the company.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to directors is a standard practice in the life sciences and diagnostics industry, aimed at aligning executive incentives with shareholder value and long-term company growth.

Related Party Transactions

• The grant of restricted stock units to Director Peter Barrett is a related party transaction, as it involves compensation to a key insider.

Stakeholder Impact

• Shareholders: The RSU grant aligns director incentives with long-term shareholder value, potentially leading to better corporate decision-making.
• Employees: Standard compensation practices for directors can indirectly influence overall company culture and compensation philosophy.
• Management: The grant reinforces the importance of continued service and performance for key executives and directors.

Next Steps

• Continued service by Peter Barrett through April 27, 2027, for full vesting of RSUs.
• Monitoring of Revvity, Inc.'s performance leading up to the vesting date.

Key Dates

Keywords

Form 4, SEC Filing, Peter Barrett, Revvity Inc, RVTY, Restricted Stock Units, RSU Grant, Beneficial Ownership, Director Compensation, Vesting Schedule